OptimizeRx 

$4.54
32
-$0.14-2.99% Tuesday 20:00
+$0.13+2.86%Tuesday 22:38盤後

統計

當日最高
4.57
當日最低
4.54
52週高點
22.25
52週低點
4.54
成交量
20,116
平均成交量
-
市值
84.63M
本益比
13
股息殖利率
-
股息
-

即將到來

財報

6Aug預期
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
下一步
-0.12
0.02
0.16
0.3
預期EPS
0.11112
實際EPS
不適用

財務

-21.83%利潤率
未盈利
2019
2020
2021
2022
2023
2024
184.25M營收
-40.22M淨利

分析師評級

12.00平均目標價
最高預估為 18.00。
來自過去6個月內的 5 則評分。這不是投資建議。
買入
80%
持有
20%
賣出
0%

其他人也在關注

此清單是根據在 Stock Events 上追蹤 OPRX 的使用者自選建立的。這不是投資建議。

競爭對手

此清單為基於近期市場事件的分析。並非投資建議。

關於

OptimizeRx Corporation is a digital health technology firm delivering a broad spectrum of solutions to life sciences organizations, healthcare providers, and patients. Its core offerings encompass financial messaging and a virtual patient support hub, enabling healthcare providers to seamlessly access sample vouchers, co-pay assistance, and other patient support resources directly within their electronic medical records (EMR) or e-prescribing platforms. The company also facilitates brand awareness and therapeutic communication through various messaging services, including targeted ads and unbranded educational content. Additionally, OptimizeRx consults with pharmaceutical manufacturers, guiding them in devising and executing effective eRx media strategies, which involves drug file integration, sales force education, and comprehensive strategy development for product promotion. It operates a cloud-based Mobile Health Messenger platform, offering interactive health messaging to bolster medication adherence and improve care coordination. Furthermore, a HIPAA-compliant automated mobile messaging platform empowers pharmaceutical companies and associated entities to directly connect with patients, fostering better regimen compliance. Patient-centric programs provide essential treatment and affordability details, alongside lifestyle and condition trackers, internet device integration, and tools for forms and surveys. For healthcare professionals, the company offers an evidence-based physician engagement solution that leverages real-world data. This tool helps identify patients suitable for particular therapies, raises awareness of patient access routes, and detects early signs of non-adherence within patient groups. Another key offering is a therapy initiation workflow designed to expedite patient access to treatments, especially those requiring extensive medical documentation from healthcare providers before pharmacists can dispense prescribed medications. Established in 2006, OptimizeRx is headquartered in Rochester, Michigan.
Show more...
執行長
Mr. Stephen L. Silvestro
員工
128
國家
美國
ISIN
US68401U2042

上市

0 Comments

分享你的想法

FAQ

OptimizeRx 今天的股價是多少?
OPRX 目前價格為 $4.54 USD,過去 24 小時下跌了 -2.99%。在圖表上更密切關注 OptimizeRx 股票的表現。
OptimizeRx 的股票代號是什麼?
根據交易所不同,股票代號可能會有所差異。例如,在 交易所,OptimizeRx 的股票以代號 OPRX 進行交易。
OptimizeRx 的股價在上漲嗎?
OPRX 股票較上週下跌 -10.63%,本月下跌 -8.1%,過去一年 OptimizeRx 下跌 -64.81%。
OptimizeRx 的市值是多少?
今天 OptimizeRx 的市值為 84.63M
OptimizeRx 下一次財報日期是什麼時候?
OptimizeRx 將於 August 06, 2026 公布下一次財報。
OptimizeRx 上一季度的財報如何?
OPRX 上一季度的財報為每股 0.14 USD,預估為 0.05 USD,帶來 +164.49% 的驚喜。下一季度的預估財報為每股 不適用 USD。
OptimizeRx 去年的營收是多少?
OptimizeRx 去年的營收為 184.25MUSD。
OptimizeRx 去年的淨利是多少?
OPRX 去年的淨收益為 -40.22MUSD。
OptimizeRx 有多少名員工?
截至 June 24, 2026,公司共有 128 名員工。
OptimizeRx 位於哪個產業?
OptimizeRx從事於Health & Wellness產業。
OptimizeRx 何時完成拆股?
OptimizeRx 上次拆股發生於 May 14, 2018,比例為 1:3。
OptimizeRx 的總部在哪裡?
OptimizeRx 的總部位於 美國 的 Waltham。